Introduction {#Sec1}
============

Ca~V~2.1 Ca^2+^ channels are plasma membrane multimeric protein complexes that play an important role in neurotransmitter release at most central brain synapses \[[@CR1]\]. Ca~V~2.1 channels are characterized by the presence of the pore-forming α~1A~ subunit that is encoded by the *Cacna1a* gene and are widely expressed throughout the nervous system \[[@CR2], [@CR3]\]. Ca~V~2.1-α~1A~-knockout (α1KO) mice that lack Ca~V~2.1 channels exhibit a severe phenotype of ataxia and dystonia with a strong cerebellar component that starts around postnatal day (P)12, and die, if not given very special care, around P20 \[[@CR4]--[@CR7]\]. Histological analysis in the few "survivors" indicated that a progressive gradual loss of Purkinje cells started between P45 and P100 \[[@CR5]\].

Cerebellar ataxia and dystonia can also be part of the phenotype of certain naturally occurring *Cacna1a* mouse mutants. For instance, *leaner*, *tottering*, *rolling Nagoya*, but not *rocker*, are characterized to different extent by granule and/or Purkinje cell death and chronic ataxia \[[@CR8]--[@CR11]\]. For *tottering* and *leaner* mice, it was shown that the chronic ataxia is related to irregular Purkinje cell simple spike firing caused by the loss of precision in intrinsic activity of Purkinje cells and aberrant synaptic input \[[@CR12]--[@CR15]\]. In addition to the cerebellar ataxia phenotype, *tottering* mice also exhibit episodic dystonia, which is related to transient low-frequency oscillations in the cerebellar cortex \[[@CR16]\]. Notably, when *tottering* mutants lose their Purkinje cells on a Purkinje cell degeneration mutant background, the dystonic phenotype disappears \[[@CR17]\]. Together these findings indicate that mutations that cause a reduction of Ca~V~2.1-mediated Ca^2+^-influx affect the information processing in the cerebellar cortex and, thereby, induce chronic ataxia and episodic dystonia.

Apart from the aberrant activity in the cerebellar cortex in *Cacna1a* mutants, also the activity of cerebellar nuclear (CN) neurons is subject to abnormal firing patterns, as was recently shown in *tottering* mice \[[@CR18]\]. Both Purkinje cells and CN neurons receive input (direct and indirect through local interneurons and/or granule cells) from mossy fibers and climbing fibers. While granule cell transmission to Purkinje cells in α1KO, *tottering*, *leaner,* and *rolling Nagoya* mice is abnormal, the response to climbing fiber activation is seemingly normal in these mutants \[[@CR15], [@CR19], [@CR20]\]. Besides the excitatory input from climbing and mossy fibers, the neurons in the CN receive input from local interneurons and from the cerebellar cortex through Purkinje cells. Apart from the impact of these inputs, the firing pattern of CN neurons is determined by their intrinsic activities. Since Purkinje cells and CN neurons, as well as the neurons and fibers that innervate them, express Ca~V~2.1 channels \[[@CR3]\], the exact origin of the aberrant cerebellar activity in Ca~V~2.1 mutants that causes cerebellar ataxia could not be resolved using the existing *Cacna1a* mouse mutants.

Therefore, we used the Cre-lox system to ablate Ca~V~2.1 channels exclusively in Purkinje cells by crossing conditional *Cacna1a* mice that carry a "floxed" allele \[[@CR21]\] with transgenic mice that express Cre recombinase under the control of the Purkinje cell-specific *Pcp2* promoter \[[@CR22]\]. Hereby, we were not only able to rescue the early lethality seen in α1KO mice, but also to demonstrate that lack of Ca~V~2.1 channel function in Purkinje cells is sufficient to cause ataxia and that progressive Purkinje cell loss starts well after the onset of the ataxia.

Materials and Methods {#Sec2}
=====================

Animals {#Sec3}
-------

All animal experiments were performed in accordance with guidelines of the respective universities and the national legislation. Previously, we generated conditional *Cacna1a* mice using a gene-targeting approach \[[@CR21]\]. The *Cacna1a* allele in these mice was "floxed" by introducing *loxP* sites flanking exon 4 (i.e. *Cacna1a*^flox^ mice) (Fig. [1a](#Fig1){ref-type="fig"}). A genomic deletion of exon 4 is achieved by crossing the conditional mice with *Pcp2*^Cre^ transgenic mice that express Cre recombinase exclusively in Purkinje cells \[[@CR22]\]. Homozygous *Cacna1a*^flox/flox^ mice were first crossed with homozygous *Pcp2*^*Cre*^ mice generating double heterozygous transgenic offspring. Female double transgenic mice were then crossed with *Cacna1a*^flox/wt^ males to generate mice that are *Cacna1a deficient* (and thereby Ca~V~2.1 channel deficient) in Purkinje cells (i.e. Purkinje cell Ca~V~2.1-α~1A~KO (PCα1KO)). The same cross also produced mice in which *Cacna1a* was not affected (wild type (WT)). In total, we used 29 PCα1KO and 29 WT littermates. Genotyping of the *Cacna1a*^flox^ allele was performed by PCR using primers P1 (5′-acctacagtctgccaggag-3′) and P2 (5′-tgaagcccagacatccttgg-3′) and genomic DNA as a template. Genomic deletion of exon 4 after Cre recombination was confirmed by PCR using primers P3 (5′-agtttctattggacagtgctggt-3′) and P4 (5′-ttgcttagcatgcacagagg-3′). For genotyping of the *Cre* transgene primers P5 (5′-acttagcctgggggtaactaaact-3′) and P6 (5′-ggtatctctgaccagagtcatcct-3′) were used.Fig. 1Generation of conditional *Cacna1a* Purkinje cell-specific knockout mice. **a** Schematic representation of the genomic structure of the relevant part of the floxed and recombined *Cacna1a* alleles. *Black boxes* indicate exons (**E**). *Triangles* indicate the position of loxP sites. *Arrows* indicate the position of the primers used for the RT-PCR. **b** RT-PCR of cerebellar RNA amplifies a 580-bp product from the non-recombined *Cacna1a* transcript and a 490-bp product from transcripts that lack exon 4. **c**--**f** Anti-Ca~V~2.1-α~1A~ immunostaining in cerebellar sections of P30 WT (**c**, **e**) and PCα1KO (**d**, **f**) mice. *CN* cerebellar nuclei, *G* granule cell layer, *M* molecular layer, *PC* Purkinje cell layer, *WM* white matter. *Roman numbers* indicate the cerebellar lobules

Reverse Transcription PCR {#Sec4}
-------------------------

Total RNA was isolated from freshly dissected cerebellum and cerebrum of mice. For RT-PCR, first-strand cDNA was synthesized using random primers. Subsequently, *Cacna1a*-specific PCRs were performed using primers P7 (5′-gatgacacggaaccatac-3′) and P8 (5′-attgtagaggagatcagtcc-3′) that are located in exon 3 and 6, respectively.

Histology {#Sec5}
---------

Mouse brains (20 PCα1KO and 20 WT) were obtained at various ages after cardiac perfusion with PBS followed by 4% buffered paraformaldehyde (PFA). Post-fixation was performed for 1 h in 4% PFA followed by overnight incubation in 10% sucrose in 0.1 M phosphate buffer at 4°C. Subsequently, the sheet of dura mater separating cerebrum and cerebellum was removed, tissue was embedded in 10% sucrose in 10% gelatine, and the gelatin was fixed with 30% sucrose in 10% PFA for 2.5 h at room temperature. This was followed by an overnight incubation in 30% sucrose in 0.1 M phosphate buffer at 4°C. Forty-micrometer sagittal sections were made using a freezing cryotome (Leica, Bensheim, Germany). Part of the sections was processed for silver staining, which selectively stains dying neurons \[[@CR23]\]. The remainder of the sections was processed directly for free-floating immunohistochemistry. Sections were incubated in 10% heat-inactivated normal horse serum (NHS) with 0.5% Triton-X100 in TBS, for 2 h and then incubated either with primary rabbit polyclonal anti-Ca~V~2.1-α~1A~ antibody (ACC-001, 1:100; Alomone Labs, Jerusalem, Israel), or with rabbit polyclonal anti-Calbindin antibody (CB38, 1:10,000; SWANT, Bellinzona, Switzerland) diluted in 1% NHS with 2% heat-inactivated fetal calf serum and 0.4% Triton-X100 in TBS at 4°C. Next, sections were washed and incubated for 2 h at room temperature with a secondary biotin-labeled goat anti-rabbit antibody (1:200; Vector Laboratories, Burlingame, CA). For protein detection, sections were incubated with the avidin-biotin-peroxidase complex (ABC kit, 1:100, Vector Laboratories) for 2 h at room temperature, and developed in 0.1 mg/ml diaminobenzidine in 0.005% H~2~O~2~. Sections were Nissl stained, air dried, and cover slipped. Paraffin-embedded cerebellar sections (5 μm) were processed for standard haematoxylin and eosin (HE) staining.

Golgi-Cox Staining {#Sec6}
------------------

Brains from 30-day-old mice (two PCα1KO and two WT) were isolated after decapitation and processed for Golgi impregnation. Brains were rinsed briefly in Milli-Q water. Tissue was further processed for Golgi-Cox staining using FD Rapid GolgiStain™ Kit (MTR Scientific, Ijamsville, MD) with 120-μm thick sections. Light microscopy images were used to assess the dendritic arborisation of Purkinje cells using the linear Sholl analysis \[[@CR24]--[@CR26]\]. In short, 7 to 11 concentric circles increasing in size (with 15 μm intervals) were aligned with the Purkinje cell soma. The number of Purkinje cell dendrites intersecting with each circle was counted. Statistical differences between groups were determined by use of repeated measures ANOVAs with one "between-subjects" factor (genotype) and one "within-subjects" factor (i.e. number of Purkinje cell dendrites intersecting with the circle) with 11 levels. The change in the dendritic branching with increasing distance within the groups was subsequently tested by use of separate repeated measures ANOVAs for each genotype with one "within-subjects" factor with 11 levels. The assumption of normality of the distributions (as tested by Kolmogorov--Smirnov tests), and equality of error variances (as tested by Levene's tests) were not violated. When the assumption of sphericity (as tested by Mauchly's tests) was violated, Greenhouse--Geisser corrections were used. All statistical analyses were performed using SPSS 17.0 software (IBM corporation, Chicago, IL, USA).

Quantification Number of Purkinje Cells and Degeneration of Purkinje Cell Axons {#Sec7}
-------------------------------------------------------------------------------

Using 40-μm thick, calbindin-stained, transversally sectioned tissue from two PCα1KO mice and three WT littermates, we calculated the average number of Purkinje cells per 100 μm of cerebellar cortex. Five to ten pictures were taken at ×20 magnification from either the vermal parts of lobule 2, 6, or 9, or from the paramedian lobule, paraflocculus, or flocculus. In each picture, the number of Purkinje cells per 100 μm of Purkinje cell layer was determined using Metamorph (Universal Imaging, Downing Town, PA, USA). In absence of many Purkinje cells the difference in structure between the molecular and granular layers guided the observer to accurately estimate the location of the Purkinje cell layer.

The extent of degeneration of Purkinje cell axons was qualitatively examined in sagittal cerebellar sections stained with silver impregnation as described elsewhere \[[@CR23]\]. For each mouse, photographs of white matter were taken with a ×5 magnification for overview and a ×40 magnification for detailed examination of degenerating fibers.

Neuronal Volume and Density Measurements {#Sec8}
----------------------------------------

Volume measurements were bilaterally taken from the medial cerebellar nuclei (MCN), anterior interposed nuclei (AIN), posterior interposed nuclei (PIN), and lateral cerebellar nuclei (LCN) using transversal, Nissl/calbindin-stained sections from three WT and three PCα1KO mice by the investigator blinded to the genotype. Contours were drawn around the four nuclei in every other section (e.g. 80-μm intervals) using NeuroLucida (MBF Bioscience, Williston, VT, USA) to construct a 3D image. Volumes (in mm^3^) were then calculated using NeuroExplorer (Nex Technologies, Littleton, MA, USA). The dorsolateral hump was included in the AIN and the "interstitial cell group" was included in the PIN. Statistical differences were determined by an independent samples Student's *t* test or an independent samples Mann--Whitney *U* test (depending on the normality of the distributions as tested by Kolmogorov--Smirnov tests). With regard to *t* tests, if the assumption of equality of variances was violated (as tested by Levene's tests), corrected degrees of freedom were used.

Neuronal surface density in the cerebellar nuclei was bilaterally determined in transversal paraffin-embedded, HE-stained cerebellar sections (4 μm) of two WT and two PCα1KO mice. For each CN, sections with a 60-μm interval were photographed at ×25 magnification (five to ten pictures per nucleus). Two independent investigators, each blinded to the genotype, counted the number of cells in each picture using Meta Imaging Series 4.6 (Molecular Devices Inc., Downingtown, PA, USA). Counting was done by drawing a contour around each CN and subsequently counting all somata with a clearly visible nucleolus by contouring the neuron's nucleus. The surface density (number of cells/mm^2^) was calculated for each section, after which the average density per CN was calculated. The total numbers of "small" and "large" cells were subsequently determined using a threshold of 8.5-μm diameter (see also Ref. \[[@CR27]\]). The 8.5-μm cut-off value was constructed using a scatter plot of the neuron nucleus' diameter from which two groups could be distinguished. Statistical differences were determined by an independent samples Student's *t* test or Mann--Whitney *U* test (depending on the normality of the distributions as tested by Kolmogorov--Smirnov tests). With regard to *t* tests, if the assumption of equality of variances was violated (as tested by Levene's tests), corrected degrees of freedom were used.

Motor Behavior Analyses {#Sec9}
-----------------------

The accelerating Rotarod (UGO Basile S.R.L., Commerio VA, Italy) test was performed on a 3 cm diameter horizontal rotating rod. The rod initially rotated at a constant speed of 4 rpm and accelerated in a stepwise manner (i.e. 4 rpm every 30 s) to a maximum of 40 rpm after 270 s. The maximum time on the rod was 300 s. The latency to fall was recorded on the moment the mouse fell down or stopped walking (i.e. clinging to the rod) for three consecutive turns and subsequently converted to the "maximum rotating speed" by calculation of the rotating speed at the moment of the fall. The test was performed in a semi-dark room with a light source placed at the bottom to discourage the mice from jumping off the rod. Mice of ∼P18 (*n* = 3 per genotype) were subjected to three trials separated by 90 min on 1 day without pre-training. Mice of P30 and P200--250 (*n* = 5 per genotype, per age group) were trained on the first day (by placing the mice on the rod that rotated with a constant speed of 5 rpm for 5 min) and then subjected to two trials separated by 30 min. On days 2 to 4, the P30 and P200--250 mice were directly subjected to two trials without pre-training. The results are presented as maximal rotating speed with mean ± SD of five mice each with two trials per day over 5 days. Statistical differences between groups were determined by use of repeated measures ANOVAs with one "between-subjects" factor (genotype) and one "within-subjects" factor (i.e. rotarod performance) with three (for ∼P18 mice) or five levels (for P30 and P200--250 mice). Rotarod performance within the groups was subsequently tested for significant changes over time by use of separate repeated measures ANOVAs for each genotype with one within-subjects factor with again three or five levels. The assumption of normality of the distributions (as tested by Kolmogorov--Smirnov tests), sphericity (as tested by Mauchly's tests) and equality of error variances (as tested by Levene's tests) were not violated.

Motor function was also assessed in P30 and P200--250 WT (*n* = 4 and 5, respectively) and PCα1KO (*n* = 4 and 5, respectively) mice using a dyskinesia rating scale that was previously described and validated in several mouse mutants \[[@CR28], [@CR29]\], including mice carrying a *Cacna1a* mutation. At the start of the experiment, each mouse was transferred to a new cage. Mice were scored for 1 min at 10-min intervals over a 60-min period. Abnormal motor behavior within the head/neck, trunk, and limbs were recorded in terms of type, including tremor (trunk, limbs, neck, and face), tonic flexion, extension (trunk, limbs, neck, and face), or twisting (trunk and neck) and clonus (limbs and face). Uncoordinated or ataxic motor behavior not attributable to a single-body part was also recorded, including falling, listing, and stumbling. Assessments of the abnormal motor behavior were then calculated by summing the dyskinesia scores during the 60-min observation period. Mice were observed on at least two separate occasions and mean dyskinesia scores were generated for each mouse. Statistical differences were determined by Mann--Whitney *U* tests, because the data were non-parametric in nature.

Results {#Sec10}
=======

Generation of Mice That Lack Ca~V~2.1 Channels in Purkinje Cells {#Sec11}
----------------------------------------------------------------

Homozygous PCα1KO mice were generated by crossing *Cacna1a*^flox/flox^ mice with transgenic mice expressing *Cre* recombinase driven by the Purkinje-specific *Pcp2* gene promoter (i.e. *Pcp2*^Cre^ mice---see "[Materials and Methods](#Sec2){ref-type="sec"}") (Fig. [1a](#Fig1){ref-type="fig"}). Successful genomic deletion of exon 4 of the *Cacna1a* gene was assessed at the RNA level by RT-PCR on cerebral and cerebellar total RNA (Fig. [1b](#Fig1){ref-type="fig"}). Whereas in the cerebrum only non-recombined PCR product of 580 bps was observed, in the cerebellum both non-recombined and recombined (480 bps) products were present. This indicated that Cre recombination only had occurred in part of the cerebellar neuron population. Immunohistochemical staining for α~1A~ protein showed that Cre recombination was Purkinje cell-specific as no protein signal was present in the soma of virtually any Purkinje neurons of PCα1KO mice (Fig. [1d, f](#Fig1){ref-type="fig"}). However, α~1A~ protein expression in other cerebellar structures, e.g. the CN, appeared not different between PCα1KO and WT mice. These findings are in line with the reported Purkinje cell specificity of the *Pcp2*^Cre^ mice \[[@CR22]\].

Motor Coordination Is Severely Affected in Purkinje Cell Ca~V~2.1-Knockout Mice {#Sec12}
-------------------------------------------------------------------------------

PCα1KO mice, unlike conventional α1KO mice \[[@CR4]--[@CR7]\], have a normal life span. PCα1KO mice appear normal until P10 to P12 when they start showing an abnormal motor phenotype with a loss of balance during walking and problems righting themselves (see [Supplementary video](#MOESM1){ref-type="media"}). Young PCα1KO ∼P18 mice (*n* = 3 per genotype) performed significantly worse on the rotarod than did their WT littermates, (*F* (1, 4) = 184.90, *p* \< 0.001) (Fig. [2a](#Fig2){ref-type="fig"}). However, there was no significant genotype X times change in performance over time interaction effect (*F* (2, 8) = 1.00, *p* = 0.41) and neither PCα1KO mice nor WT mice showed an improvement over time (*F* (2, 4) = 2.00, *p* = 0.25 and *F* (2, 4) = 7.11, *p* = 0.54, respectively). This indicates that although WT mice performed significantly better on the rotarod, the young age and/or the intensity of the training (more repeats during this 1-day protocol induced fatigue in the ∼P18 WT mice as also seen with a P40 WT mouse (data not shown)) prevented a significant improvement. Rotarod experiments of PCα1KO mice tested at P30 (*n* = 5 per genotype) consisted of two trials per day for five consecutive days and revealed that these mice were severely impaired, in that they were not able to stay on the accelerating rod for longer than 60 ± 7.8 s on the fifth day (Fig. [2b](#Fig2){ref-type="fig"}), which corresponded to a rotating speed of 8 rpm. This maximum rotating speed was significantly slower than that in WT mice, which stayed on the accelerating rod for 272 ± 19.1 s on the fifth day, which corresponds to a rotating speed of 40 rpm (*F* (1, 8) = 1297.32, *p* \< 0.001) (Fig. [2b](#Fig2){ref-type="fig"}). Additionally, there was a significant genotype X change in performance over time interaction effect (*F* (4, 32) = 4.89, *p* \< 0.01), indicating that there was a significant difference in change in performance over time between the two groups. More specifically, whereas the WT mice significantly improved their performance over time (*F* (4, 16) = 7.14, *p* \< 0.01), the PCα1KO mice did not (*F* (4, 16) = 0.48, *p* = 0.75). Using a similar rotarod protocol for P200--250 mice (*n* = 5 per genotype), we found the same extend of motor deficit (Fig. [2c](#Fig2){ref-type="fig"}). PCα1KO mice of P200--250 were not able to stay on the accelerating rotarod for more than 57 ± 14.3 s on the fifth day and fell off at a significantly lower rotating speed than did wild type mice (*F* (1, 8) = 908.84, *p* \< 0.001) who managed to stay on the rotarod for 248 ± 28.4 s on the fifth day. Although the genotype X change in performance over time interaction effect was not significant, it did show a clear trend (*F* (4, 32) = 2.47, *p* = 0.064). This trend is confirmed since PCα1KO mice did not show an improvement over time (*F* (4, 16) = 0.87, *p* = 0.51), whereas WT mice did (*F* (4, 16) = 4.07, *p* \< 0.02). These data should, however, be interpreted with caution in the sense that lack of improvement on the rotarod test in PCα1KO mice does not necessarily reflect a learning deficit, e.g. the ataxic phenotype may have prevented an improvement in performance in this test.Fig. 2Abnormal motor behavior in *Cacna1a* Purkinje cell-specific knockout mice. **a**--**c** Rotarod testing revealed severe impairments in motor performance of PCα1KO mice compared to WT littermates. The latency to fall is expressed as the maximal rotating speed in rotations per min (*rpm*) for P18 (**a**), P30 (**b**), and P200--250 (**c**) PCα1KO mice and WT littermates. **d**, **e** Additional assessment of motor behavior to classify by type of movement disorder. **d** P30 PCα1KO mice (*n* = 5) but not WT littermates (*n* = 5) showed ataxic movements, tremors, tonic, and clonic movements. Note the predominant ataxic component. **e** P200-250 PCα1KO mice (*n* = 5) but not WT littermates (*n* = 5) showed ataxic movements, tremors, tonic, and clonic movements. Note the similarity in behavioral classification between P30 and P200--250 PCα1KO mice

Because it is difficult to determine the specific deficit that causes impaired rotarod performance, motor function was also assessed using a dyskinesia rating scale (see "[Materials and Methods](#Sec2){ref-type="sec"}" for details). There was significantly more ataxia compared to tremor, tonic movements, or clonic movements in both P30 PCα1KO (*n* = 4) mice (ataxia vs. tremor: *U* = 16.00, *p* \< 0.01; ataxia vs. tonic: *U* = 16.00, *p* \< 0.01; ataxia vs. clonic: *U* = 16.00, *p* \< 0.01) and P200--250 PCα1KO mice (*n* = 5; ataxia vs. tremor: *U* = 25.00, *p* \< 0.01; ataxia vs. tonic: *U* = 25.00, *p* \< 0.01; ataxia vs. clonic: *U* = 25.00, *p* \< 0.01) (Fig. [2d, e](#Fig2){ref-type="fig"}). Ataxia, but not other movements, was significantly increased in young (P30) PCα1KO mice compared with age-matched WT mice (*n* = 4; *U* = 16.00, *p* \< 0.01), whereas all abnormal movement types were significantly increased in old (P200--250) PCα1KO mice compared with age-matched WT littermates (*n* = 5; ataxia: *U* = 25.00, *p* \< 0.01; tremor: *U* = 25.00, *p* \< 0.01; tonic: *U* = 25.00, *p* \< 0.01; clonic: *U* = 25.00, *p* \< 0.01). In PCα1KO mice, there was a slight but significant increase in tremor with age (*U* = 20.00, *p* \< 0.01) and a trend for an increase in ataxia and clonus with age (*U*~*s*~ = 18 and 17, respectively), but their relative contribution to the abnormal motor behavior in mutant mice remained similar irrespective of their age.

To study whether the severe ataxia in young PCα1KO mice come about due to structural abnormalities, we studied the cytoarchitecture at P30 in more detail (Fig. [3](#Fig3){ref-type="fig"}). Both a standard HE staining and a more detailed Golgi-Cox staining did not reveal qualitative differences between PCα1KO and WT littermates. Topological analysis of the dendritic branching of Purkinje cells from two WT mice (i.e. 25 cells) and three PCα1KO mice (i.e. 30 cells) showed no significant difference (*F* (1, 40) = 0.00, *p* = 0.98) between groups, nor was there a significant genotype X change in the dendritic branching with an increasing distance interaction effect (*F* (3.385, 135.397) = 1.03, *p* = 0.39). In both the WT and PCα1KO mice, the amount of dendritic branching did significantly change with increasing distance (*F* (3.281, 82.024) = 42.13, *p* \< 0.001 and *F* (3.002, 45.036) = 20.09, *p* \< 0.001, respectively). These data indicate that, although PCα1KO mutants are severely ataxic already at P18, their Purkinje cells did not reveal structural abnormalities.Fig. 3Overall cerebellar and Purkinje cell morphology in young *Cacna1a* Purkinje cell-specific knockout mice. Haematoxilin and eosin staining reveals similar gross cerebellar morphology in PCα1KO (**a**) and WT (**b**) mice at P30. *G* granule cell layer, *PC* Purkinje cell layer, *M* molecular layer, *WM* white matter. *Roman numbers* indicate the cerebellar lobules. Golgi-Cox-stained cerebellar sections of PCα1KO (**c**) and WT (**d**) mice at P30 reveal normal morphology of the Purkinje cells in the two genotypes; **e** PCα1KO mice show similar level of dendrite arborization (linear Sholl analysis, for details see "[Materials and Methods](#Sec2){ref-type="sec"}") as their WT littermates

Progressive Cell Death of Purkinje Cells in the Absence of Ca~V~2.1 Channels {#Sec13}
----------------------------------------------------------------------------

As Ca~V~2.1 channels gate more than 90% of the high-voltage-gated Ca^2+^-influx in Purkinje cells, the morphology and survival of Purkinje cells in the PCα1KO mutants may be affected at later stages in their life. Therefore, we compared calbindin D28K-stained cerebellar sections of PCα1KO mice at various ages (i.e. P30, P60, P100, and P200--250) (Fig. [4](#Fig4){ref-type="fig"}). In line with the topological analysis described above, the immunostaining of the cerebellar cortex of PCα1KO mutants at P30 did not show overt differences with those of WT littermates (Fig. [4a](#Fig4){ref-type="fig"}). At later ages, however, we observed substantial Purkinje cell degeneration in the cerebellum of PCα1KO mice (Fig. [4b--d](#Fig4){ref-type="fig"}). Starting at P60, Purkinje cells showed degenerative structural abnormalities, such as somatic sprouting and axonal swellings (Fig. [4b--d](#Fig4){ref-type="fig"}). These changes progressed until P200--250, at which PCα1KO mice (*n* = 2) showed a significant decrease in Purkinje cell number compared with WT controls (*n* = 3) (lobule 2, *U =* 0.00*, p* \< 0.001; lobule 6, *U =* 28.00*, p* \< 0.001; lobule 9, *U =* 1.00*, p \<* 0.001; paramedical lobule, *U =* 0.00*, p* \< 0.001; paraflocculus, *U =* 179.00*, p* \< 0.001; flocculus, *U =* 0.00*, p* \< 0.001) (Fig. [4e](#Fig4){ref-type="fig"}). Although the extent of the degeneration of Purkinje cells is evident, also the variability between various lobules is apparent. Given that we did not find any anti-Ca~V~2.1-α~1A~ staining in the Purkinje cells of PCα1KO mice (see Fig. [1c--f](#Fig1){ref-type="fig"}), this variability in the Purkinje cell death could not be explained by inter-cellular variations in the *Cre* expression or the recombination efficacy of the LoxP/Cre system.Fig. 4Calbindin D 28K staining of sagittal cerebellar sections of *Cacna1a* Purkinje cell-specific knockout mice at different ages. **a** Calbindin staining reveals normal foliation of the cerebellum at P30 in PCα1KO mice. Purkinje cells are organized in regular rows with no evidence of abnormal morphology. **b** Purkinje cell loss, particularly in the anterior lobes of PCα1KO mice at P60. Abnormalities in Purkinje cell morphology, such as axonal swellings (*arrowheads in inset*), can be seen. **c** Progressive Purkinje cell loss in PCα1KO mice at P100 is now also more prominent in posterior lobes. Axonal swellings are indicated by *arrowheads*. **d** Further evidence of the progressive nature of the Purkinje cell degeneration in PCα1KO mice at P200--250. Remaining Purkinje cells often show axonal swelling (*arrowhead*). *Roman numbers* indicate the cerebellar lobules. *G* granule cell layer, *PC* Purkinje cell layer, *M* molecular layer, *WM* white matter. **e** Purkinje cell degeneration in different cerebellar lobules of P200--250 PCα1KO mice. Quantification of the number of Purkinje cells (*PCs*) per 100 μm in different lobules in WT (*blue*; *n* = 3) and PCα1KO (*green*; *n* = 2) mice. The number of Purkinje cells is significantly decreased in all lobules of PCα1KO mice compared to WT littermates

Neurodegenerative Changes in Cerebellar Cortex {#Sec14}
----------------------------------------------

In order to visualize dying neurons, we used silver impregnation on tissue from mice at various ages (Fig. [5](#Fig5){ref-type="fig"}). At P30, PCα1KO mice showed very little argyrophylic staining (Fig. [5a, d](#Fig5){ref-type="fig"}), indicating that there are no overt degenerative changes in their cerebellum, despite their ataxia. However, at P45 the level of argyrophylic staining in PCα1KO mice dramatically increased. Many silver-stained somata, axons, and dendrites of dying Purkinje cells were randomly dispersed throughout the cerebellar cortex (Fig. [5b, e](#Fig5){ref-type="fig"}). Still, at this stage we did not observe any secondary cell death of neurons in the granular layer or molecular layer. In contrast at P200--250, both layers in PCα1KO mice contained dying neurons (Fig. [5c, f](#Fig5){ref-type="fig"}). Apparently, the loss of their target cells---the Purkinje cells---resulted in loss of part of the granule cells and molecular layer interneurons. Moreover, we observed silver-stained Purkinje cell axons in the white matter surrounding the cerebellar nuclei (Fig. [6](#Fig6){ref-type="fig"}). The density of these degenerating fibers is variable throughout the white matter, as can be expected from the alternating density of Purkinje cell axons in cerebellar white matter depending on their efferent targets \[[@CR30], [@CR31]\] and the non-uniform distribution of Purkinje cell degeneration (Fig. [4e](#Fig4){ref-type="fig"}).Fig. 5Silver impregnation of cerebellar sections in *Cacna1a* Purkinje cell-specific knockout mice. **a**, **d** No apparent neurodegeneration is seen in the cerebellum of PCα1KO mice at P30. **b**, **e** Silver-stained Purkinje cell bodies as well as dendrites and axons indicating dying cells in the cerebellum of PCα1KO mice at P45. *Arrows* indicate dying Purkinje cells in (**e**). **c**, **f** No Purkinje cells are present the respective areas. Silver-stained cells can be found in the granular and molecular layers indicating some granule and interneuron loss at P200--250. *G* granule cell layer, *PC* Purkinje cell layer, *M* molecular layer, *WM* white matter. *Roman numbers* indicate the cerebellar lobules. *Dotted boxes* in (**a**--**c**) correspond to regions shown in (**d**--**f**)Fig. 6Silver impregnation of cerebellar section reveal stained axons surrounding the medial cerebellar nuclei in *Cacna1a* Purkinje cell-specific knockout mice. **a**--**d** Silver-stained Purkinje cells and their axons are found in PCα1KO mice at P60 (**c**, **d**) but not in tissue from WT littermates (**a**, **b**). *Dotted boxes* in (**a**, **c**) correspond to regions shown in (**b**, **d**)

Neurodegenerative Changes in Cerebellar Nuclei {#Sec15}
----------------------------------------------

The loss of Purkinje cells in PCα1KO may not only have an effect on *upstream* neurons in the cerebellar cortex, but also on *downstream* neurons in the cerebellar nuclei. To test for loss of Purkinje cell target neurons, we calculated the volume (in mm^3^) and surface density (in number of cells/mm^2^) of the MCN, AIN, PIN, and LCN in PCα1KO and WT mice at age P200--250. The volume quantification revealed pronounced volume reductions in all cerebellar nuclei of PCα1KO mice compared to those of WT mice, (LCN: *t* (10) = 8.63, *p* \< 0.001; AIN: *t* (10) = 8.86, *p* \< 0.001; PIN: *U* = 3.00, *p* \< 0.02; MCN: *U* = 0.00, *p* \< 0.01; total volume: *U* = 0.00, *p* \< 0.01) (Table [1](#Tab1){ref-type="table"}) (Fig. [7a--c](#Fig7){ref-type="fig"}). The surface density was significantly increased in all cerebellar nuclei of PCα1KO mice compared to those of WT mice (LCN: *t* (6) = −3.43, *p* \< 0.02; AIN: *t* (6) = −4.99, *p* \< 0.01; PIN: *t* (6) = −2.94, *p* \< 0.03; MCN: *t* (3.354) = −4.19, *p* \< 0.03) (Table [1](#Tab1){ref-type="table"}) (Fig. [7d](#Fig7){ref-type="fig"}). The increased surface density also appeared in the total density of "small cells" (nucleus, \<8.5 μm in diameter) averaged for all nuclei (*M* = 262.5 ± 47.8 for WT and 509.9 ± 111.3 for PCα1KO mice, *t* (6) = −4.09, *p* \< 0.01) (Fig. [7e](#Fig7){ref-type="fig"}) but not for the "large cells" (nucleus, \>8.5 μm in diameter; *M* = 178.3 ± 21.1 for WT and 198.0 ± 11.4 for PCα1KO mice, *t* (6) = −1.65, *p* = 0.151) (Fig. [7f](#Fig7){ref-type="fig"}). Thus, a general decrease in volume and an increase in cell density can be seen with the exception of an unchanged "large cell" density.Table 1Volume and surface density in the cerebellar nuclei (CN)NucleusWTPCα1KOVolume (mm^3^)Density (cells/mm^2^)Volume (mm^3^)Density (cells/mm^2^)LCN0.125 ± 0.016494.3 ± 83.40.057 ± 0.011842.6 ± 185.2AIN0.196 ± 0.026370.0 ± 81.10.087 ± 0.015696.5 ± 102.9PIN0.089 ± 0.030504.8 ± 41.10.046 ± 0.008668.0 ± 103.0MCN0.198 ± 0.004394.1 ± 26.00.089 ± 0.015624.5 ± 106.8Total0.608 ± 0.0710.280 ± 0.039The volume (mm^3^) and surface density (cells/mm^2^) are represented for the lateral CN (LCN), anterior interposed CN (AIN), posterior interposed CN (PIN), and medial CN (MCN), as well as for the total CNFig. 7Changes in volume and neuronal density in cerebellar nuclei of P200--250 PCα1KO and WT mice. **a**--**c** Quantification of the volume of the cerebellar nuclei in WT (*blue*; *n* = 3) and PCα1KO (*green*; *n* = 3) mice. **a** Example of a bilateral 3D reconstruction of the cerebellar nuclei of one WT (*top*) and one PCα1KO mouse (*bottom*). *Light blue* lateral cerebellar nucleus (*LCN*), *dark blue* anterior interposed nucleus (*AIN*), *purple* posterior interposed nucleus (*PIN*) and *gray* medial cerebellar nucleus (*MCN*). **b** An average decrease of 54% in the total volume of the cerebellar nuclei in PCα1KO mice is shown. **c** Quantification of the volume of individual cerebellar nuclei reveals a pronounced volume reduction in all four nuclei. **d** Overall neuronal surface density of CN neurons per individual CN. **e** Surface density of small cells (\<8.5 μm in diameter). **f** Surface density of big cells (\>8.5 μm in diameter). \**p* \< 0.05; \*\**p* \< 0.001 (significant differences among groups)

Discussion {#Sec16}
==========

Here we used conditional gene targeting to ablate Ca~V~2.1 calcium channels selectively in Purkinje cells in vivo in mice. This approach allowed us to study the specific contribution of these channels in Purkinje cells to the development of ataxia that is associated with mutations in the *Cacna1a* gene. Our cell type-specific knockout strategy using conditional *Cacna1a*-knockout mice \[[@CR21]\] succeeded in circumventing early postnatal lethality that is a very prominent feature in *Cacna1a*-knockout mice that lack Ca~V~2.1 channels in all neurons \[[@CR4]--[@CR7]\]. In line with the well-defined expression of Cre recombinase in Purkinje cells in *Pcp2*^Cre^ mice \[[@CR22]\], Cre recombination affected α~1A~ expression in almost all Purkinje neurons, as is evident by the lack of anti-α~1A~ staining in these cells at P30 while α~1A~ expression seemed preserved in the rest of the brain (data not shown). We could demonstrate that lack of Ca~V~2.1 channels in Purkinje cells is sufficient to cause an ataxic phenotype since the ataxia occurred prior to structural abnormalities. This finding adds to existing lines of evidence \[[@CR8]--[@CR11]\], which indicate that the cerebellar ataxia associated with abnormal Ca~V~2.1 channel function can be caused by Purkinje cell dysfunction.

Interestingly, our PCα1ΚΟ mutants exhibited a predominantly ataxic phenotype without episodic motor attacks during the first months of life. Notably, recently developed *Cacna1a*^purk(−/−)^ mice, which lack functional Ca~V~2.1 channels due to a Purkinje cell specific deletion of exon 1 of the *Cacna1a* gene, were reported to have dyskinesia attacks from 3 weeks on \[[@CR32]\]. Intrinsically generated low-frequency oscillations in the cerebellum of *tottering* mice are thought to be the source of the episodic motor attacks in these mutants \[[@CR16]\]. Further evidence for this hypothesis came from microinjections of the non-selective voltage-sensitive K^+^-channel blocker 3,4 DiAP in the cerebellum of *tottering* mice that abolished the episodic attacks of dyskinesia \[[@CR33]\]. Future experiments will have to show whether similar mechanisms in the cerebellum of PCα1KO underlie the episodic nature of dyskinesia.

Visual inspection of the mice revealed that the ataxia in PCα1KO mice started at P10--12, around the same age as in conventional α1KO mice that lack Ca~V~2.1 channels in all neurons \[[@CR4]--[@CR7]\]. Likewise, loss of Ca~V~2.1 function in Purkinje cells did not affect normal development of the cerebellar cortex, similar to what was shown for conventional Ca~V~2.1KO mice \[[@CR4], [@CR5]\] and *Cacna1a*^purk(−/−)^ mice \[[@CR32]\]. These findings are in line with the fact that during the first postnatal week Ca~V~1 (L-type) channels are the dominant voltage-gated Ca^2+^ channel type in Purkinje cell somata \[[@CR34]\]. At this time, however, we cannot rule out the possibility that other high-voltage-gated calcium channels, such as Ca~V~2.2 (N-type) and Ca~V~2.3 (R-type), are upregulated during later stages in PCα1KO mice and thereby rescue partly the detrimental effects of Ca~V~2.1 absence. Similar compensatory mechanisms involving Ca~V~2.2, Ca~V~2.3, and Ca~V~1 have been described in other *Cacna1a* mutant mice at the level of neurotransmission \[[@CR15], [@CR17], [@CR32], [@CR35]\].

The first signs of neurodegenerative changes in PCα1KO mice were observed around P45. At this stage, silver impregnation revealed clear argyrophylic staining in the Purkinje cell and molecular layers. From P60 on, Purkinje cell loss was clearly visible and many of the remaining Purkinje cells showed abnormalities such as torpedo's or axonal swellings. At older ages (P100 and P200--250), Purkinje cell loss became progressively worse and ultimately also affected the survival of neurons in the granular layer and molecular layer. In *lurcher* and Purkinje cell degeneration (*Pcd*) mice, which both show near-complete Purkinje cell loss in adulthood, a progressive postnatal Purkinje cell degeneration is also followed by large scale death of granule cells after the loss of Purkinje cells \[[@CR36]--[@CR38]\]. Thus, the fact that three completely different mutations lead to the same sequence of cerebellar events (for *lurcher* see Ref. \[[@CR39]\]; for *Pcd* see Ref. \[[@CR40]\]) indicates that the degeneration of granule cells and molecular layer interneurons is probably a common, secondary effect to the loss of Purkinje cells.

Downstream Effects of Widespread Purkinje Cell Loss {#Sec17}
---------------------------------------------------

The loss of Purkinje cells also affected the cerebellar nuclei in PCα1KO mice. The extent of volume reduction in PCα1KO mice was similar to that reported in *lurcher* and *Pcd* mouse mutants \[[@CR27], [@CR41]\]. In *lurcher* mice deafferentation of the CN resulted in a ∼60% reduction in the volume of all individual CN \[[@CR27]\]. We also found a widespread increase in neuronal surface densities in all CN. However, it appeared that the increase in neuronal density is more pronounced in small cells than in large cells. Despite the fact that our results do not allow a firm statement about the total number of cells per CN, our data seems to indicate a possible reduction in the number of large neurons. The data presented here shows a somewhat different pattern from *lurcher* mutants with regard to cell density \[[@CR27]\]. Future experiments should provide a more detailed picture of the total number of neurons per cell type per CN.

Behavioral Effects of Widespread Purkinje Cell Loss {#Sec18}
---------------------------------------------------

The abnormal motor behavior in both young and old PCα1KO mice was dominated by ataxic movements. Since the behavioral abnormalities were already visible before the degeneration occurred (i.e. in young P18 and P30 PCα1KO mice), this indicates that the lack of functional Ca~V~2.1 channels in Purkinje cells can induce the same behavioral aberrations as an absence of Purkinje cells (i.e. in old P200--250 PCα1KO mice). The severity of the ataxic symptoms in PCα1KO mice was also reflected by the fact that, unlike the WT controls, the mutants did not show an increase in their performance on the rotarod over time. Whether there is cerebellar motor learning deficit in the PCα1KO mice could not be assessed since motor learning (i.e. showing improved performance on the rod over time) may have been obscured by the severity of the ataxic phenotype. The severe effect on motor coordination in PCα1KO mice is likely to be due to the disrupted Purkinje cell output and the subsequent deregulation of activity patterns downstream \[[@CR18], [@CR42]\], which might be relatively normal, at least initially, as was described for *lurcher* mice \[[@CR43]\].

Summary {#Sec19}
-------

This report represents a cell type-specific ablation of Ca~V~2.1 channels leading to a disease phenotype. We demonstrate that specific ablation of these channels in Purkinje cells is sufficient to cause cerebellar ataxia that precedes progressive Purkinje cell loss. Conditional *Cacna1a* mice appear especially useful for dissecting the cell-specific role of Ca~V~2.1 channels in neuronal circuitries such as in the cerebellum and in revealing the mechanisms underlying human disease.
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